These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3554702)

  • 21. Prospective randomized controlled study of prophylaxis with cefamandole in high risk patients undergoing operations upon the biliary tract.
    Cáinzos M; Potel J; Puente JL
    Surg Gynecol Obstet; 1985 Jan; 160(1):27-32. PubMed ID: 3917304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
    Cohen E; Mogabgab WJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():253-60. PubMed ID: 6296017
    [No Abstract]   [Full Text] [Related]  

  • 23. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical studies of efficacy of piperacillin against complicated urinary tract infections].
    Ikeuchi T; Yogi S; Ueno M; Morikawa F; Onodera Y; Sakamoto M; Kai Y
    Hinyokika Kiyo; 1986 Jan; 32(1):143-50. PubMed ID: 3962805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections.
    File TM; Tan JS; Gardner WG; Baird I
    J Antimicrob Chemother; 1983 Jan; 11(1):75-82. PubMed ID: 6219089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of cefamandole on urinary tract and genital organ infections (author's transl)].
    Doi S; Fujimoto A; Ito M; Sugimoto O; Tsujii K
    Jpn J Antibiot; 1980 Apr; 33(4):411-5. PubMed ID: 6997528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind evaluation of ceftizoxime versus cefamandole therapy for urinary tract infections.
    Penn RL
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():241-5. PubMed ID: 6296014
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of piperacillin in surgical prophylaxis of genitourinary infections.
    Childs SJ; Mirelman S; Wells G
    Urology; 1985 Jul; 26(1 Suppl):43-8. PubMed ID: 3892854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
    Kaye KS; Bhowmick T; Metallidis S; Bleasdale SC; Sagan OS; Stus V; Vazquez J; Zaitsev V; Bidair M; Chorvat E; Dragoescu PO; Fedosiuk E; Horcajada JP; Murta C; Sarychev Y; Stoev V; Morgan E; Fusaro K; Griffith D; Lomovskaya O; Alexander EL; Loutit J; Dudley MN; Giamarellos-Bourboulis EJ
    JAMA; 2018 Feb; 319(8):788-799. PubMed ID: 29486041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of urologic infections with cefamandole (Pharmachim)--the microbiological and clinical results].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1986; 25(4):32-8. PubMed ID: 3765588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piperacillin therapy for complicated urinary tract infections caused by enterococci alone and in association with multi-drug resistant pathogens.
    Gesu GP; Manca E; Pompei R; Stefani S; Zedda MS; Russo G; Satta G; Schito GC
    Chemioterapia; 1987 Jun; 6(2 Suppl):508-10. PubMed ID: 3334611
    [No Abstract]   [Full Text] [Related]  

  • 34. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.
    Kauf TL; Prabhu VS; Medic G; Borse RH; Miller B; Gaultney J; Sen SS; Basu A
    BMC Infect Dis; 2017 Apr; 17(1):314. PubMed ID: 28454524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised comparison of ceftriaxone and cefamandole therapy in lower respiratory tract infections in an elderly population.
    Bittner MJ; Pugsley MP; Horowitz EA; Strike DG; Sanders CC; Preheim LC
    J Antimicrob Chemother; 1986 Nov; 18(5):621-7. PubMed ID: 3804884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefamandole: pharmacokinetics and therapeutic evaluation in urology.
    Zinati AH; Naber KG
    Arzneimittelforschung; 1980; 30(5):839-42. PubMed ID: 7190432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefamandole treatment of pulmonary infection caused by gram-negative rods.
    Mandell GL
    Scand J Infect Dis Suppl; 1980; suppl 25():107-11. PubMed ID: 7010535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefamandole nafate therapy in the treatment of acute urinary tract infections.
    Short HD; Gentry LO; Sessoms S
    J Antimicrob Chemother; 1976 Dec; 2(4):345-50. PubMed ID: 802125
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics].
    Kiliç H; Karahan M
    Mikrobiyol Bul; 1991 Jan; 25(1):28-35. PubMed ID: 1881356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.